Segal Institute for Clinical Research Launches New Employee Recognition Program
In honor of Clinical Trials Awareness Day, Segal Institute has implemented a new employee recognition program, the Diamond Club, to acknowledge their greatest asset – their staff.
Dr. Steven Chavoustie of Segal Institute Listed as an Author on Research Paper
Segal Institute for Clinical Research’s Dr. Steven Chavoustie helped to author the research paper, “Experts explore the state of bacterial vaginosis and the unmet needs facing women and providers,” recently published in the International Journal of Gynecology & Obstetrics, the official publication of the International Federation of Gynecology and Obstetrics (FIGO).
Curemark Announces Further Expansion of Clinical Sites For Its Phase 3 Clinical Trial for Children with Autism
Curemark, LLC announced today that the Blüm Study, a Phase 3 clinical trial to evaluate the safety and efficacy of CM-AT in children aged 3-8 with Autism, is now enrolling at three new sites. These new sites are in addition to the 30 clinical sites already enrolling children across the United States….
Segal Institute for Clinical Research Takes Essential Step to Reduce Duplicate Enrollment In Clinical Trials
Segal Institute for Clinical Research has chosen Verified Clinical Trials (VCT), the global clinical trial database registry utilizing biometric fingerprint technology, to counter attempts at duplicate enrollment in clinical trial research and improve the safety of research volunteers and data quality…
Mental Health Organizations Work Together to Educate, Support and Encourage People to Take Action against an Illness that affects Millions of People Every Year
People are diagnosed with mental illness every day. Statistics alone would alarm anyone unfamiliar with the condition; a rare occurrence, as mental disorders affect one in four people…
Segal Institute for Clinical Research Proudly Participates in Phase 3 Efficacy Trial of Long-acting Treatment Opioid Dependence
Segal Institute for Clinical Research has three Principal Investigators currently participating in Braeburn Pharmaceuticals and Camurus’ Phase 3 efficacy Trial of Long-acting Treatment for Opioid …
Segal Institute Recognized as Top Fundraiser for Namiwalk Broward County
Segal Institute for Clinical Research was recently recognized as the top fundraiser at the annual NAMIWalk Broward County during NAMI Broward County’s Holiday Party, Volunteer Recognition and Walk…
Dr.Rishi Kakar of Segal Institute for Clinical Research Listed as an Author on Research Paper
Segal Institute for Clinical Research’s Dr. Rishi Kakar helped to author the research paper, “A Selective Nociceptin Receptor Antagonist to Treat Depression: Evidence from…